Document is current
Any future updates will be listed below
-
Authors
Lehto, Mika https://orcid.org/0000-0002-8691-5142
Halminen, Olli https://orcid.org/0000-0001-9266-8435
Mustonen, Pirjo https://orcid.org/0000-0003-1319-0248
Putaala, Jukka https://orcid.org/0000-0002-6630-6104
Linna, Miika https://orcid.org/0000-0002-7660-2484
Kinnunen, Janne
Kouki, Elis
Niiranen, Jussi https://orcid.org/0000-0001-7751-6257
Hartikainen, Juha https://orcid.org/0000-0003-0847-107X
Haukka, Jari https://orcid.org/0000-0003-1450-6208
Airaksinen, Kari Eino Juhani https://orcid.org/0000-0002-0193-568X
-
Funding
Funding for this research was provided by:
Aarne Koskelon Säätiö
Sydäntutkimussäätiö
Helsingin ja Uudenmaan Sairaanhoitopiiri (TYH2019309)
University of Helsinki including Helsinki University Central Hospital
- License Information
-
More Information
Article History
Received: 7 December 2020
Accepted: 28 September 2021
First Online: 5 January 2022
Declarations
:
: Mika Lehto: Consultant: BMS-Pfizer-alliance, Bayer, Boehringer-Ingelheim, and MSD; Speaker: BMS-Pfizer-alliance, Bayer, Boehringer-Ingelheim, MSD, Terve Media and Orion Pharma. Research grants: Aarne Koskelo Foundation, The Finnish Foundation for Cardiovascular Research, and Helsinki and Uusimaa Hospital District research fund, Boehringer-Ingelheim. Olli Halminen: none. Pirjo Mustonen: Consultant: Roche, BMS-Pfizer-alliance, Novartis Finland, Boehringer Ingelheim, MSD Finland. Jukka Putaala: Consultant: Boehringer-Ingelheim, Bayer, BMS-Pfizer, Abbott/St. Jude Medical, Vital Signum, Nokia Technologies, Bittium, BcB Medical, Herantis Pharma, Medixine, and Portola. Speaker: Boehringer-Ingelheim, Bayer, BMS-Pfizer, and Terve Media; Research grants: BMS-Pfizer, Abbott/St. Jude Medical, Business Finland, and Amgen. Miika Linna: Speaker: BMS-Pfizer-alliance, Bayer, Boehringer-Ingelheim. Janne Kinnunen: none. Jussi Niiranen: none. Elis Kouki: none. Juha Hartikainen: Research grants: The Finnish Foundation for Cardiovascular Research, Advisory Board Member: BMS-Pfizer-alliance, Novo Nordisk, Amgen. Speaker: Cardiome, Bayer. Jari Haukka: Consultant: Research Janssen R&D; Speaker: Bayer Finland. K.E. Juhani Airaksinen: Research grants: The Finnish Foundation for Cardiovascular Research; Speaker: Bayer, Pfizer and Boehringer-Ingelheim. Member in the advisory boards: Bayer, Pfizer and AstraZeneca.
: This study was performed in line with the principles of the Declaration of Helsinki, and the ethical permission is permitted by ethical committee of the Medical Faculty of Helsinki University, Helsinki Finland (nr. 15/2017).
